Action of recombinant interferons and interleukin 2 in modulating radiation effects on viability and cytotoxicity of large granular lymphocytes.
暂无分享,去创建一个
[1] J. Ritz,et al. Biology and clinical relevance of human natural killer cells. , 1990, Blood.
[2] M. Vitale,et al. Radiosensitivity of human natural killer cells: binding and cytotoxic activities of natural killer cell subsets. , 1990, Radiation research.
[3] P W Mansell,et al. Pharmacokinetics of recombinant interleukin 2 in humans. , 1990, Cancer research.
[4] R. Cameron,et al. Synergistic antitumor activity of tumor-infiltrating lymphocytes, interleukin 2, and local tumor irradiation. Studies on the mechanism of action , 1990, The Journal of experimental medicine.
[5] H. Strander,et al. Recombinant leukocyte interferon alpha-2a and medroxyprogesterone in advanced renal cell carcinoma. A randomized trial. , 1990, Acta oncologica.
[6] J. Dubois,et al. The influence of interleukin-2, feeder cells, and timing of irradiation on the radiosensitivity of human T lymphocytes assessed by the colony-forming assay. , 1989, Radiation research.
[7] D. Zarcone,et al. Radiation sensitivity of resting and activated nonspecific cytotoxic cells of T lineage and NK lineage. , 1989, Blood.
[8] S. Sone,et al. Differential Effects of Recombinant Interferons α, β, and γ on Induction of Human Lymphokine (IL–2)–Activated Killer Activity , 1988 .
[9] R. Dutkowski,et al. Eradication of mouse melanoma by combined treatment with recombinant human interleukin 2 and recombinant murine interferon‐gamma , 1988, International journal of cancer.
[10] J. Barankiewicz,et al. Metabolic consequences of DNA damage: alteration in purine metabolism following poly(ADP ribosyl)ation in human T-lymphoblasts. , 1987, Archives of biochemistry and biophysics.
[11] D. Samid,et al. Interferon-induced revertants of ras-transformed cells: resistance to transformation by specific oncogenes and retransformation by 5-azacytidine , 1987, Molecular and cellular biology.
[12] S. Clark,et al. Effects of interferons and interleukin 2 on natural killing of cytomegalovirus-infected fibroblasts. , 1987, Clinical and experimental immunology.
[13] J. Rinehart,et al. Phase I/II Trial of Human Recombinant β-Interferon Serine in Patients with Renal Cell Carcinoma , 1986 .
[14] J. Rinehart,et al. Phase I/II trial of human recombinant interferon gamma in renal cell carcinoma. , 1986, Journal of biological response modifiers.
[15] L. Olson,et al. DNA fragmentation in targets of CTL: an example of programmed cell death in the immune system. , 1985, Advances in experimental medicine and biology.
[16] S. Rosenberg. Immunotherapy of cancer by systemic administration of lymphoid cells plus interleukin-2. , 1984, Journal of biological response modifiers.
[17] R. Mertelsmann,et al. Generation of nonspecific murine cytotoxic T cells in vitro by purified human interleukin 2. , 1984, Cellular immunology.
[18] L. Kangas,et al. Bioluminescence of cellular ATP: a new method for evaluating cytotoxic agents in vitro. , 1984, Medical biology.
[19] M. Green,et al. Radiosensitivity of human T-lymphocytes proliferating in long term culture. , 1983, International journal of radiation biology and related studies in physics, chemistry, and medicine.
[20] H. Blomgren,et al. In vitro radiosensitivity of the spontaneous cytotoxicity of blood lymphocytes in patients with untreated Hodgkin's disease. , 1983, European journal of cancer & clinical oncology.
[21] S. Pestka,et al. Effects of several species of human leukocyte interferon on cytotoxic activity of NK cells and monocytes , 1983, International journal of cancer.
[22] B. Stadler,et al. Cultures of purified human natural killer cells: growth in the presence of interleukin 2. , 1982, Cellular immunology.
[23] S. Rosenberg,et al. Lymphokine-activated killer cell phenomenon. Lysis of natural killer- resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes , 1982, The Journal of experimental medicine.
[24] C Brovall,et al. Radiation sensitivity of human natural killer cell activity: control by X-linked genes. , 1981, Journal of immunology.
[25] J. Ortaldo,et al. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells , 1981, The Journal of experimental medicine.
[26] E. Saksela,et al. Isolation of human NK cells by density gradient centrifugation. , 1980, Journal of immunological methods.
[27] S. Pestka,et al. Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma. , 1980, Annals of internal medicine.
[28] K. Cantell,et al. Human Natural Killer Cell Activity is Augmented by Interferon via Recruitment of ‘Pre‐NK’ Cells , 1979, Scandinavian journal of immunology.
[29] H. Pross,et al. Spontaneous human lymphocyte‐mediated cytotoxicity againts tumour target cells. I. The effect of malignant disease , 1976, International journal of cancer.
[30] I. Gresser,et al. Mechanism of the Antitumour Effect of Interferon in Mice , 1972, Nature.
[31] Albrecht M. Kellerer,et al. THEORY OF DUAL RADIATION ACTION. , 1972 .
[32] T. Puck,et al. ACTION OF X-RAYS ON MAMMALIAN CELLS , 1956, The Journal of experimental medicine.